Copyright
©The Author(s) 2018.
World J Gastroenterol. Sep 14, 2018; 24(34): 3919-3926
Published online Sep 14, 2018. doi: 10.3748/wjg.v24.i34.3919
Published online Sep 14, 2018. doi: 10.3748/wjg.v24.i34.3919
Table 1 Demographic information stratified by adenomatous polyp prevalence n (%)
Adenoma absent | Adenoma present | Total | P value | |
Total | 436 (58.2) | 313 (41.79) | 749 (100) | |
Age | 0.043 | |||
Mean ± SD | 58.656 ± 7.321 | 59.764 10 ± 7.417 | 59.119 ± 7.376 | |
Gender | 0.798 | |||
Male | 180 (41.3) | 133 (42.5) | 313 (41.8) | |
Female | 256 (58.7) | 180 (57.5) | 436 (58.2) | |
Race | 0.243 | |||
White | 29 (6.7) | 33 (10.6) | 62 (8.3) | |
African american | 104 (23.9) | 74 (23.7) | 178 (23.8) | |
Asian | 5 (1.1) | 2 (0.6) | 7 (0.9) | |
Hispanic | 298 (68.3) | 203 (65.1) | 501 (67.0) | |
Indication of colonoscopy | 0.279 | |||
Surveillance | 77 (17.7) | 66 (21.1) | 143 (19.1) | |
Screening | 359 (82.3) | 247 (78.9) | 606 (80.9) |
Table 2 Adenoma prevalence by risk-score quintile for all patients
NCI lifetime risk score quintile | Score range | Number of individuals with adenomas (%) | OR of an adenoma (95%CI): row quintile vs column quintile | |||
Q1 | Q2 | Q3 | Q4 | |||
Q1 lowest | (1.1, 1.9) | 42 (27.63) | - | - | - | - |
Q2 | (1.9, 2.8) | 55 (33.54) | 1.32 (0.82, 2.14) | - | - | - |
Q3 | (2.8, 4.0) | 69 (46.31) | 2.26 (1.40, 3.65) | 1.71 (1.08, 2.70) | - | - |
Q4 | (4.0, 5.4) | 71 (52.21) | 2.86 (1.75, 4.67) | 2.16 (1.36, 3.45) | 1.27 (0.79, 2.02) | - |
Q5 highest | (5.4, 12.3) | 76 (51.35) | 2.76 (1.71, 4.47) | 2.09 (1.32, 3.30) | 1.22 (0.78, 1.93) | 0.97 (0.61, 1.54) |
Table 3 Disease prevalence stratified by risk score optimal cutoff value n (%)
< 3.6 (n = 373) | ≥ 3.6 (n = 376) | Total (n = 749) | P value | |
Adenoma present | 115 (30.8) | 198 (52.7) | 313 (41.8) | < 0.001 |
Adenoma (number) | < 0.001 | |||
< 3 | 355 (95.2) | 321 (85.4) | 676 (90.3) | |
≥ 3 | 18 (4.8) | 55 (14.6) | 73 (9.7) | |
Serrated adenoma present | 1 (0.3) | 2 (0.5) | 3 (0.4) | 1.000 |
Hyperplastic polyp > 10 mm present | 7 (1.9) | 10 (2.7) | 17 (2.3) | 0.632 |
Table 4 Adenoma prevalence by risk-score quintile for all screening patients
NCI lifetime risk score quintile | Score range | Number of individuals with adenomas (%) | OR of an adenoma (95%CI): row quintile vs column quintile | |||
Q1 | Q2 | Q3 | Q4 | |||
Q1 lowest | (1.1, 1.9) | 35 (28.69) | - | - | - | - |
Q2 | (1.9, 2.8) | 45 (33.58) | 1.26 (0.74, 2.14) | - | - | - |
Q3 | (2.8, 4.0) | 52 (43.70) | 1.93 (1.13, 3.29) | 1.53 (0.92, 2.56) | - | - |
Q4 | (4.0, 5.5) | 62 (51.67) | 2.66 (1.56, 4.52) | 2.11 (1.27, 3.51) | 1.38 (0.83, 2.29) | - |
Q5 highest | (5.5, 12.3) | 53 (47.75) | 2.27 (1.32, 3.90) | 1.81 (1.08, 3.03) | 1.18 (0.70, 1.98) | 0.85 (0.51, 1.43) |
- Citation: Tariq H, Kamal MU, Patel H, Patel R, Ameen M, Elona S, Khalifa M, Azam S, Zhang A, Kumar K, Baiomi A, Shaikh D, Makker J. Predicting the presence of adenomatous polyps during colonoscopy with National Cancer Institute Colorectal Cancer Risk-Assessment Tool. World J Gastroenterol 2018; 24(34): 3919-3926
- URL: https://www.wjgnet.com/1007-9327/full/v24/i34/3919.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i34.3919